Science

Diego Díaz García: Immunotherapy for advanced-stage SqNSCLC

Diego Díaz García/X

Feb 25, 2025, 08:54

Diego Díaz García: Immunotherapy for advanced-stage SqNSCLC

Diego Díaz García, Medical Oncologist, CEO and Founder of CánCare, shared a post on X about a paper by Yibei Wang et al. published in Nature Reviews Clinical Oncology:

“Immunotherapy for advanced-stage SqNSCLC: the state of the art.

Comprehensive overview of current immunotherapeutic approaches, unresolved challenges and emerging strategies.”

“Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions”

Authors: Yibei Wang, Mohammed Safi, Fred Hirsch, Shun Lu, Solange Peters, Ramaswamy Govindan, Rafael Rosell, Keunchil Park, Jianjun Zhang.

Diego Díaz García: Immunotherapy for advanced-stage SqNSCLC

More posts featuring Diego Díaz García.

cancer Diego Díaz García Fred Hirsch immunotherapy Jianjun Zhang Keunchil Park Mohammed Safi OncoDaily Oncology Rafael Rosell Ramaswamy Govindan Shun Lu Solange Peters SqNSCLC squamous cell lung cancer Yibei Wang

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC